Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy

Muller, Alexander J, DuHadaway, James B, Donover, P Scott, Sutanto-Ward, Erika, Prendergast, George C·2005·Nature Medicine

DOI 10.1038/nm1196

Cited by (999)

Items 801–900 of 999

Chemo-immunotherapy by nanoliposomal epacadostat and docetaxel combination to IDO1 inhibition and tumor microenvironment suppression
Rahimeh Khoshkhabar, Mona Yazdani, Seyedeh Hoda Alavizadeh, Zahra Saberi, Leila Arabi, Mahmoud Reza Jaafari · 2024 · International Immunopharmacology
A difficult diagnosis of H odgkin lymphoma due to immune thrombocytopenia
Silvia Marino, Andrea Di Cataldo, Gaetano Giuseppe Magro, Salvatore D’Amico, Milena La Spina, Vincenzo Di Benedetto, Mariaclaudia Meli, Carla Moscheo, Giovanna M. Russo · 2015 · Clinical Case Reports
Interaction of current cancer treatments and the immune system: implications for breast cancer therapeutics
Peng Tan, Amrit S. Lota · 2008 · Expert Opinion on Pharmacotherapy
Binding Properties of Different Categories of Ido1 Inhibitors: A Microscale Thermophoresis Study
Francesco Antonio Greco, Alice Coletti, Chiara Custodi, Daniela Dolciami, Alessandro Di Michele, Andrea Carotti, Maura Marinozzi, Nina Schlinck, Antonio Macchiarulo · 2017 · Future Medicinal Chemistry
Indoleamine 2, 3-dioxygenase and B7-H1 expressions as prognostic and follow-up markers in human pancreatic carcinoma
Liancai Wang, Qingyong Ma, Deyu Li, Senmao Mu, Yong Li, Ya-Feng Wang, Pengfei Shi, Haibo Yu, Chunhui Gao, Kun Guo et al. · 2018 · Pathology - Research and Practice
Investigation of indolamine 2, 3 dioxygenase ( IDO‐1 ) gene expression by real‐time PCR among patients with lung cancer
Mojtaba Haji Mazdarani, Milad Jafarikia, Fahimeh Nemati · 2019 · Journal of Cellular Physiology
Sialylated N-glycan profile during acute and chronic infections with Toxoplasma gondii in mice
Ibrahim F. Rehan, Motamed Elsayed Mahmoud, Doaa Salman, Asmaa Elnagar, Saleh M. Salman, Mohammed Youssef, Amer Ragheb Abdel Aziz, Eman Kamal Bazh, Abd El‐Latif Hesham · 2020 · Scientific Reports
Future of immunotherapy in pancreas cancer and the trials, tribulations and successes thus far
Winston Wong, Emily Linda Alouani, Alexander Z. Wei, Yun Kyoung Ryu, John A. Chabot, Gulam Abbas Manji · 2021 · Seminars in Oncology
Untangling huge literature to disinter genetic underpinnings of Alzheimer’s Disease: A systematic review and meta-analysis
Hema Sree G N S, V. Lakshmi Prasanna, Kshreeraja S. Satish, Abhijna Vithal Yergolkar, Mamatha Krishnamurthy, Saraswathy Ganesan Rajalekshmi, K Radhika, Raghunadha Reddy Burri · 2021 · Ageing Research Reviews
Prognosis prediction and tumor immune microenvironment characterization based on tryptophan metabolism-related genes signature in brain glioma
Shuxin Zhang, Siliang Chen, Zhihao Wang, Junhong Li, Yunbo Yuan, Wentao Feng, Wenhao Li, Mina Chen, Yanhui Liu · 2022 · Frontiers in Pharmacology
Anti-inflammatory strategies for the treatment of multiple sclerosis – tryptophan catabolites may hold the key
Michael Platten, Peggy Pui-Kay Ho, Lawrence Steinman · 2006 · Drug Discovery Today Therapeutic Strategies
Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responses
Tania Køllgaard, Tobias Wirenfeldt Klausen, Manja Idorn, Rikke Holmgaard, Per thor Straten, Mads Hald Andersen · 2012 · OncoImmunology
The Role of the Placental Enzyme Indoleamine 2,3-Dioxygenase in Normal and Abnormal Human Pregnancy
Yoshiki Kudo, Jun Sugimoto · 2024 · International Journal of Molecular Sciences
Metal‐organic frameworks‐based nanomedicines to promote cancer immunotherapy: Recent advances and future directions
Chenqian Feng, Xiaoyan Liang, Rangrang Fan, Min Mu, Liangxue Zhou, Gang Feng Guo · 2024 · MedComm – Biomaterials and Applications
Identification of novel kynurenine production-inhibiting benzenesulfonamide derivatives in cancer cells
Shintaro Nakano, Kazushige Takai, Yoshinobu Isaka, SUSUMU Y. TAKAHASHI, Yuka Unno, Naohisa Ogo, Kenji Matsuno, Osamu Takikawa, Akira Asai · 2012 · Biochemical and Biophysical Research Communications
Association between Cyclooxygenase-2 and Indoleamine 2,3-Dioxygenase Expression in Breast Cancer Patients from Pakistan
Kashif Asghar, Asif Loya, Iftikhar Ali Rana, Muhammad Abu Bakar, Asim V. Farooq, Muhammad Tahseen, Muhammad Ishaq, Muhammad Usman Rashid · 2019 · Asian Pacific Journal of Cancer Prevention
A highly efficient modality to block the degradation of tryptophan for cancer immunotherapy: locked nucleic acid-modified antisense oligonucleotides to inhibit human indoleamine 2,3-dioxygenase 1/tryptophan 2,3-dioxygenase expression
Richard Klar, Sven Michel, Monika Schell, Lisa Hinterwimmer, Alfred Zippelius, Frank Jaschinski · 2019 · Cancer Immunology Immunotherapy
BIN1 in cancer: biomarker and therapeutic target
Siyu Chen, Jinlong Cao, Kunpeng Li, Shun Wan, Yang Li · 2023 · Journal of Cancer Research and Clinical Oncology
The Potential Strategies for Overcoming Multidrug Resistance and Reducing Side Effects of Monomer Tubulin Inhibitors for Cancer Therapy
Yingjie Cui, Jing Zhang, Guifang Zhang · 2023 · Current Medicinal Chemistry
Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors
Chuan Zhou, Fangfang Lai, Sheng Li, Xiaoguang Chen, Yan Li, Zhiqiang Feng · 2020 · Molecules
Conformational Dynamics Contribute to Substrate Selectivity and Catalysis in Human Kynureninase
Christos S. Karamitros, Kyle Murray, Yusuke Sugiyama, Yoichi Kumada, Kenneth Allen Johnson, George Georgiou, Sheena D’Arcy, Everett M Stone · 2020 · ACS Chemical Biology
Review of 10 years of research on breast cancer patients: Focus on indoleamine 2,3-dioxygenase
K. Asghar, Asim Farooq, Bilal Zulfiqar, A. Loya · 2021 · World Journal of Clinical Oncology
Clinical aspects of indoleamine 2,3-dioxygenase (IDO)-initiated tryptophan metabolism: IDO is a target of drug discovery for various diseases
Osamu Takikawa · 2007 · International Congress Series
Targeting Metabolic Pathways in Kidney Cancer
Christian R. Hoerner, Susanna Y. Miao, James J.-D. Hsieh, Alice C. Fan · 2020 · The Cancer Journal
Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects
Pengfei Gu, Bin Ling, Weike Ma, Jinming Zhang, Wei Zhang, Yu Zeng, Yu Liu, Jiadong Chi, Xianhui Ruan, Xiangqian Zheng et al. · 2022 · BMC Cancer
Targeting Metabolic Reprogramming in Tumor: From Mechanisms to Precision Immunotherapies
Tong Zhang, Ping Gao, Linchong Sun · 2025 · MedComm – Oncology
Emerging role of immunotherapy in urothelial carcinoma—Future directions and novel therapies
Jong‐Chul Park, Noah M. Hahn · 2016 · Urologic Oncology Seminars and Original Investigations
Role of Indoleamine-2,3-Dioxygenase Inhibitors in Salvage Therapy for Non-Muscle Invasive Bladder Cancer
Carissa Ellen Chu, Sima P. Porten, Gary D. Grossfeld, Maxwell V. Meng · 2019 · Urologic Clinics of North America
Synthesis and activity study of novel N,N-diphenylurea derivatives as IDO1 inhibitors
Xixi Hou, Zi-Yuan Wu, An Zhan, En Gao, Longfei Mao, Hui-Li Wang, Jianxue Yang · 2023 · Frontiers in Chemistry
IDO in Inflammatory Programming and Immune Suppression in Cancer
George C. Prendergast, Courtney Smith, Sunil Thomas, Laura Mandik‐Nayak, Lisa D. Laury‐Kleintop, Richard A. Metz, Alexander J. Muller · 2014 · Springer eBooks
On the metabolic origin of cancer: substances that target tumor metabolism
Maurice Israël, Laurent H. Schwartz · 2011 · Biomedical Research-tokyo
Inhibition of immunosuppressive indoleamine 2,3-dioxygenase by targeting the heme and apo-form
Nirmalya Pradhan, Nasim Akhtar, Barnali Nath, Jorge Jpg Peña-García, Anjali Gupta, Horacio Pérez‐Sánchez, Sachin Kumar, Debasis Manna · 2020 · Chemical Communications
Inhibition of indoleamine 2,3-dioxygenase 1 synergizes with oxaliplatin for efficient colorectal cancer therapy
Xiaofei Miao, Ye Zhang, Zengyao Li, Longchang Huang, Taojian Xin, Renhui Shen, Tong Wang · 2021 · Molecular Therapy — Methods & Clinical Development
Indoleamine 2,3‐dioxygenase gene expression and kynurenine to tryptophan ratio correlation with nasopharyngeal carcinoma progression and survival
Sameh Souissi, Randa Ghedira, Yosra Macherki, Ahlem Ben‐Haj‐Ayed, Sallouha Gabbouj, Yasmine Remadi, Imen Sfar, Zohra Chadli, Karim Aouam, Mohsen Hassine et al. · 2022 · Immunity Inflammation and Disease
Ligand migration in human indoleamine‐2,3 dioxygenase
Karin Nienhaus, Elena Nickel, Changyuan Lu, Syun‐Ru Yeh, Gerd Ulrich Nienhaus · 2011 · IUBMB Life
A Powerful Yeast-Based Screening Assay for the Identification of Inhibitors of Indoleamine 2,3-Dioxygenase
M. Cerejo, Gonçalo Andrade, C. Roca, J. Sousa, Cátia Rodrigues, Ricardo Pinheiro, Sukalyan Chatterjee, Helena Vieira, Patrícia Calado · 2012 · Journal of biomolecular screening
Preclinical PK investigation of a novel IDO1/TDO dual inhibitor—SHR9146 in mouse plasma and tissues by LC-MS/MS
Mei Xiao, Kan Zhong, Li Guo, Wei Li, Xiaoli Wang, Zhenjun Qiu, Taijun Hang · 2023 · Frontiers in Oncology
Exploring a repurposed candidate with dual hIDO1/hTDO2 inhibitory potential for anticancer efficacy identified through pharmacophore-based virtual screening and in vitro evaluation
Nourhan M. Aboomar, Omar Essam, Afnan Hassan, Ahmad Raafat Bassiouny, Reem K. Arafa · 2024 · Scientific Reports
Cancer Immunotherapy: Silencing Intracellular Negative Immune Regulators of Dendritic Cells
Yaohua Liu, I‐Jeng Yeh, Ming‐Derg Lai, Kuan‐Ting Liu, Po‐Lin Kuo, Meng‐Chi Yen · 2019 · Cancers
Indoleamine 2,3-Dioxygenase-1 Expression is Changed During Bladder Cancer Cell Invasion
Hellen Joyce Sousa Pereira Santos, Luiz Henrique Gomes Matheus, Aline Silva, Stephanie Vanin Dalmazzo, Andressa Assunção dos Santos, Leticia Rafaela Alves Rubens dos Santos, Diego Mota Souza, Sabrina T. Reis, Ivan P. Nascimento, Humberto Dellê · 2022 · International Journal of Tryptophan Research
Analysis of Tryptophan and Its Main Metabolite Kynurenine and the Risk of Multiple Cancers Based on the Bidirectional Mendelian Randomization Analysis
Ran Li, Xuanyang Wang, Yuntao Zhang, Xiaoqing Xu, Lulu Wang, Chunbo Wei, Lin Liu, Ziqi Wang, Ying Li · 2022 · Frontiers in Oncology
The exploitation of enzyme-based cancer immunotherapy
Gourav Chandan, Adesh Kumar Saini, Reena Kumari, Sasanka Chakrabarti, Amit Mittal, Anil Kumar Sharma, Reena Vohra Saini · 2022 · Human Cell
Synthesis of the Reported Pyranonaphthoquinone Structure of the Indoleamine-2,3-dioxygenase Inhibitor Annulin B by Regioselective Diels–Alder Reaction
Martyn W. Inman, Catarina Carvalho, William Lewis, Christopher J. Moody · 2016 · The Journal of Organic Chemistry
Magnetic Resonance Imaging in the Clinical Evaluation of Lung Disorders: Current Status and Future Prospects
Linyu Wu, Chen Gao, Ting Wu, Ning Kong, Ziwei Zhang, Jie Li, Li Fan, Maosheng Xu · 2025 · Journal of Magnetic Resonance Imaging
Natural products targeting the metabolism of amino acids: from discovery to synthetic development
Hyun Su Kim, Ahmed H.E. Hassan, Kyuho Moon, Jaehoon Sim · 2025 · Natural Product Reports
Prodrug-tethered lipid nanoparticles for synergistic messenger RNA cancer immunotherapy
Qiangqiang Shi, Ningqiang Gong, Jinjin Wang, Rohan Palanki, Qiuxian Zheng, Mohamad‐Gabriel Alameh, Garima Dwivedi, Benjamin Davis, Jilian R. Melamed, Zhangyi Luo et al. · 2026 · Nature Nanotechnology
Effects of sex and hydration status on kappa opioid receptor‐mediated diuresis in rats
Hasnain M. Lalji, Christopher P. Bailey, Stephen M. Husbands, Sarah Bailey · 2024 · Basic & Clinical Pharmacology & Toxicology
Attenuated Negative Feedback in Monocyte-Derived Macrophages From Persons Living With HIV: A Role for IKAROS
Celeste Faia, Karlie Plaisance-Bonstaff, Cecilia Vittori, D. Wyczechowska, A. Lassak, Mary Meyaski-Schluter, K. Reiss, F. Peruzzi · 2021 · Frontiers in Immunology
Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls
Andrea Mammoli, Elisa Bianconi, Luana Ruta, Alessandra Riccio, Carlo Bigiotti, Maria Souma, Andrea Carotti, Sofia Rossini, Chiara Suvieri, Maria Teresa Pallotta et al. · 2022 · International Journal of Molecular Sciences
Inhibitor of Indoleamine-2,3-Dioxygenase 1-Methyl-D-Tryptophan Can Stimulate the Growth of Immunogenic Tumors
E. D. Vasil’eva, V. P. Nikolin, Nelly A. Popova, Elena L. Lushnikova, В. И. Каледин · 2010 · Bulletin of Experimental Biology and Medicine
Synthesis, crystal structures and electronic properties of isomers of chloro-pyridinylvinyl-1H-indoles.
L. Moineaux, S. Laurent, Jérémy Reniers, Eduard Dolušić, M. Galleni, J. Frère, B. Masereel, R. Frédérick, J. Wouters · 2012 · European journal of medicinal chemistry
Conformational-Analysis-Guided Discovery of 2,3-Disubstituted Pyridine IDO1 Inhibitors
Emily C. Cherney, Liping Zhang, Weiwei Guo, Audris Huang, David Williams, Steven P. Seitz, Weifang Shan, Xiao Zhu, Johnni L. Gullo-Brown, Derrick Maley et al. · 2021 · ACS Medicinal Chemistry Letters
Increased Activity of the Immunoregulatory Enzyme Indoleamine-2,3-Dioxygenase with Consecutive Tryptophan Depletion Predicts Death in Patients with Neuroendocrine Neoplasia
R. Pschowski, U. Pape, G. Fusch, C. Fischer, H. Jann, A. Baur, R. Arsenic, B. Wiedenmann, S. von Haehling, M. Pavel et al. · 2016 · Neuroendocrinology
Recent update on the discovery of indoleamine-2,3-dioxygenase 1 inhibitors targeting cancer immunotherapy
Man Gao, Wenqian Yu, Zhuo Xi, Zai-Li Zhang, Xiaoxue Fan, Xiaoyan Wang · 2025 · European Journal of Medicinal Chemistry
Structural Basis of Selective Human Indoleamine‐2,3‐dioxygenase 1 (hIDO1) Inhibition
Shaymaa Emam Kassab, Samar Mowafy · 2021 · ChemMedChem
Tumor and dendritic cell dual-targeting nanocarriers maximize the therapeutic potential of IDO1 inhibitor in vivo
Tong Yu, Xiangyu Jin, Fangying Yu, Xiqin Yang, Yingping Zeng, Tingting Meng, Hong Yuan, Fuqiang Hu · 2022 · Nano Research
Tryptophan intake and pancreatic cancer: findings from a case-control study
Hung Nguyen Luu, Yen Thi‐Hai Pham, Jian‐Min Yuan, Randall E. Brand, Tuyen Van Pham, Hang Viet Dao, Chung Thi-Kim Le, Nhi Yen Ngoc Huynh, Hai Minh Nguyen, Ngoan Tran Le · 2024 · European Journal of Cancer Prevention
Parallel Expression of Enzyme Inhibitors of CD8T Cell Activity in Tumor Microenvironments and Secretory Endometrium
Joyce A. Ibana, Sandra Jelyn Cutay, Maevel Romero, Danny Joseph Schust · 2015 · Reproductive Sciences
T lymphocytes to IDO+ cells: check
Cailin Moira Wilke, Weiping Zou · 2011 · Blood
Inhibitors of the Kynurenine Pathway
Ute F. Röhrig, Vincent Zoete, Olivier Alain Michielin · 2017 · Topics in medicinal chemistry
Forkhead box P3 and indoleamine 2,3-dioxygenase co-expression in Pakistani triple negative breast cancer patients
Kashif Asghar, Asif Loya, Iftikhar Ali Rana, Muhammad Abu Bakar, Asim V. Farooq, Muhammad Tahseen, Muhammad Ishaq, Iqra Masood, Muhammad Usman Rashid · 2020 · World Journal of Clinical Oncology
Small Molecule Regulators Targeting NAD+ Biosynthetic Enzymes
Yana Cen, Alyson M. Curry, Dawanna S. White · 2021 · Current Medicinal Chemistry
Synthesis and Intracellular Redox Cycling of Natural Quinones and Their Analogues and Identification of Indoleamine‐2,3‐dioxygenase (IDO) as Potential Target for Anticancer Activity
Christopher E. Blunt, Canan Torcuk, Yang Liu, William Lewis, David M. Siegel, David Ross, Christopher J. Moody · 2015 · Angewandte Chemie
Hypomethylation-induced regulatory programs in T cells unveiled by transcriptomic analyses
Memnon Lysandrou, Panagiota Stamou, Dionysia Kefala, Chryso Pierides, Maria Kyriakou, Nikolaos Savvopoulos, Panayiota Christofi, Αναστασία Παπαδοπούλου, Evangelia Yannaki, Paul Costeas et al. · 2023 · Frontiers in Immunology
The combination of IDO and AHR blockers reduces the migration and clonogenicity of breast cancer cells
Maryam Soltani-asl, Parviz Azimnasab-sorkhabi, Túlio Teruo Yoshinaga, Cristina de Oliveira Massoco, José Roberto Kfoury · 2023 · Immunologic Research
Immune Surveillance in Health and Diseases of Aging: Definitions of Acute and Chronic Inflammation [Yin and Yang]
Mahin Khatami · 2017 · Springer eBooks
Insights on Peptide Vaccines in Cancer Immunotherapy
Kwong Yok Tsang, Caroline Jochéms, Jeffrey Schlom · 2015 · Cancer drug discovery and develogment/Cancer drug discovery and development
Monooxygenase Activity of Indoleamine 2,3-Dioxygenase
Ali B. Lubis, A. Bailey, Marko Hanževački, Christopher Williams, Mehul H. Jesani, Lola González‐Sánchez, Christopher J. Arthur, Hannah C. Wilson, Andrea E. Gallio, P.C.E. Moody et al. · 2026 · Journal of the American Chemical Society
Dynamic immuno-nanomedicines in oncology
Hao Ling, Qinyi Zhang, Qiuhua Luo, Defang Ouyang, Zhonggui He, Jin Sun, Mengchi Sun · 2023 · Journal of Controlled Release
Assessment of an Anticancer Effect of the Simultaneous Administration of MM-129 and Indoximod in the Colorectal Cancer Model
Iwona Kwiatkowska, Justyna Magdalena Hermanowicz, Robert Czarnomysy, Arkadiusz Surażyński, Krystyna Kowalczuk, Joanna Kałafut, Alicja Przybyszewska-Podstawka, Krzysztof Bielawski, Adolfo Rivero‐Müller, Mariusz Mojzych et al. · 2023 · Cancers
Comparative Analysis of Breast Cancer Metabolomes Highlights Fascin’s Central Role in Regulating Key Pathways Related to Disease Progression
Reem H. AlMalki, Huda K. Al-Nasrallah, Alanoud Aldossry, Rayanah Barnawi, Samiyah Al‐Khaldi, Sheema Almozyan, Mysoon M. Al‐Ansari, Hazem Ghebeh, Anas M. Abdel Rahman, Monther M Al-Alwan · 2024 · International Journal of Molecular Sciences
Tumor immune evasion mediated by IDO
David H. Munn · 2006 · Update on Cancer Therapeutics
Indoleamine 2,3-Dioxygenase Activity-Induced Acceleration of Tumor Growth, and Protein Kinases-Related Novel Therapeutics Regimens
Ayşe Başak Engin, Atilla Engin · 2021 · Advances in experimental medicine and biology
Influence of the Metabolism on Myeloid Cell Functions in Cancers: Clinical Perspectives
Thomas Boyer, Céline Blaye, Nicolas Larmonier, Charlotte Domblides · 2022 · Cells
NAD+ as a Target for Cancer Treatment
Tessa J. Helman, Nady Braidy · 2023 · Springer eBooks
The Role of Regulatory T Cells and Indoleamine-2,3-dioxygenase in Brain Tumor Immunosuppression
Mahua Dey, Alan Lee Chang, Jason M. Miska, Jian Qiao, Maciej S. Lesniak · 2017 · Elsevier eBooks
El potencial de la inmunomodulación con anticuerpos monoclonales anti-CD137 (4-1BB) para terapia de enfermedades malignas e infecciones virales crónicas
Carlos Alfaro, Oihana Murillo, Iñigo Tirapu, Arantza Azpilicueta, Eduardo Huarte, Ainhoa Arina, Laura Arribillaga, José Luis Perez‐Gracia, Maurizio Bendandi, Jesús Prìeto et al. · 2006 · Anales del Sistema Sanitario de Navarra
Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancer
James B. DuHadaway, George C. Prendergast · 2016 · Oncotarget
Use of RIP1 Kinase Small-Molecule Inhibitors in Studying Necroptosis
Allison M. Beal, John Bertin, Michael Reilly · 2018 · Methods in molecular biology
Tumor-Associated Myeloid-Derived Suppressor Cells
Stephanie K. Bunt, Erica M. Hanson, Pratima Sinha, Minu K. Srivastava, Virginia K. Clements, Suzanne Ostrand‐Rosenberg · 2007 · Elsevier eBooks
The Effect of Repetitive Transcranial Magnetic Stimulation With Different Stimulation Methods on Post‐Stroke Dysphagia: A Network Meta‐Analysis
Li Jiayao, Liu Zejian, Zhao Henan, Chen Yuan, Qi Hongjing, Zhang Jun, Sun Jie · 2025 · Journal of Oral Rehabilitation
Regulated necrosis at the crossroads of liver inflammation and cancer development
Mihael Vucur, Vangelis Kondylis, Petr Brož, Tom Luedde · 2025 · Nature Reviews Gastroenterology & Hepatology
Carrier-free PANoptosis nanoinducers synergize with immunometabolic reprogramming for enhanced immunotherapy
Zilin Ma, Songyan Li, Wen Zhao, Binhan Liu, Xuechun Wang, Yilei Zhao, Yunxuan Song, Jianwei Jiao, Yueying Zhang, Guiqiang Zhang et al. · 2026 · Journal of Controlled Release
Prognostic and predictive value of IDO expression in metastatic melanoma treated with Ipilimumab
Dagmar von Bubnoff, Christina Schmitt, Simone M. Goldinger, Dirk Schadendorf, Katharina Charlotte Kähler, Christian Matthias Hafner, Nora Kramer, Waltraud Fröhlich, Reinhard Dummer, Carola Berking et al. · 2025 · PLoS ONE
Calcium-pterin suppresses mitogen-induced tryptophan degradation and neopterin production in peripheral blood mononuclear cells
Christiana Winkler, Katharina Schroecksnadel, Phillip B. B. Moheno, Eric Meerbergen, Harald Schennach, Dietmar Fuchs · 2006 · Immunobiology
Evaluation and comparison of the commonly used bioassays of human indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO)
Shengnan Zhang, Leilei Guo, Dan Yang, Zikang Xing, Weirui Li, Chunxiang Kuang, Qing Yang · 2020 · Bioorganic Chemistry
Emerging immune-based technologies for high-grade gliomas
Alice Giotta Lucifero, Sabino Luzzi · 2022 · Expert Review of Anticancer Therapy
Total Synthesis of Racemic Benzomalvin E, a Quinazolinone Isolated from Pencilium sp. FN070315 and Exploration to the Direct Synthesis of (E)-Benzomalvin B
Soumya Jyoti Basak, Jyotirmayee Dash · 2024 · The Journal of Organic Chemistry
Immune Escape: Immunosuppressive Networks
Shuang Wei, Alfred E. Chang, Weiping Zou · 2007 · Elsevier eBooks
Reliable detection of indoleamine 2,3 dioxygenase-1 in murine cells and tissues
Sunil Thomas, Lisa D. Laury‐Kleintop, George C. Prendergast · 2019 · Methods in enzymology on CD-ROM/Methods in enzymology
Assessment of interferon gamma and indoleamine 2,3-dioxygenase 1 analysis during respiratory syncytial virus infection in infants in Italy: an observational case–control study
Francesco Savino, Valentina Daprà, Andrea Savino, Cristina Calvi, Paola Montanari, Ilaria Galliano, Massimiliano Bergallo · 2022 · BMJ Open
Nanotechnology for Cancer Vaccine Delivery
Samar Ismail Hamdy, Aws Alshamsan, John Samuel · 2008 · Springer eBooks
Evaluation of Tryptophan Metabolism in Chronic Immune Activation
A. Engin · 2015 · Molecular and integrative toxicology
Molecular Modeling of Proteins: From Simulations to Drug Design Applications
Vincent Zoete, Michel A. Cuendet, Ute F. Röhrig, Aurélien Grosdidier, Olivier Alain Michielin · 2009 · WORLD SCIENTIFIC eBooks
Immunohistochemical expression of CB1 receptors in the liver of patients with HBV related-HCC
Bita Moudi, Mohammad-Reza Mohades, Hamidreza Mahmoudzadeh‐Sagheb, Zahra Heidari · 2022 · Arab Journal of Gastroenterology
Combined Inhibition of Indolamine-2,3-Dioxygenase 1 and C-X-C Chemokine Receptor Type 2 Exerts Antitumor Effects in a Preclinical Model of Cervical Cancer
Solangy Lizcano‐Meneses, Rogélio Hernández‐Pando, Ian García‐Aguirre, José Bonilla‐Delgado, Víctor Manuel Alvarado-Castro, Bulmaro Cisneros, Patricio Gariglio, Enoc Mariano Cortés-Malagón · 2023 · Biomedicines
An exploratory study on the effect of kynurenine metabolites on sEnd‐2 endothelioma cells
Danielle Sandra Nkandeu, Anna Margaretha Joubert, June Cheptoo Serem, Priyesh Bipath, Yvette Nkondo Hlophe · 2024 · Cell Biochemistry and Function
Iridium( iii )/rhenium( i ) complexes bearing NLG919 as the ligand for enhanced triple-negative breast cancer therapy
Hou Zhu, Yong-Sheng Yang, Lin-Yuan Zhu, Chun-Rong Jiang, Zheng Zhang, Mengting Xu, Rong‐Tao Li, Rui‐Rong Ye · 2025 · Dalton Transactions
Mitochondria-targeted iridium(III)-PF-06840003 conjugates: Apoptosis induction, IDO inhibition and ICD response
Chun-Rong Jiang, Yongsheng Yang, Lin-Yuan Zhu, Mengting Xu, Rong‐Tao Li, Rui‐Rong Ye · 2025 · Journal of Inorganic Biochemistry
Tryptophan-kynurenine pathway: a possible new mechanism for the prevention and treatment of reproductive system-related diseases
Zhongkai Ou, Aixia Xu, Hua Su, Yiting Liu, Jia Li · 2025 · PeerJ